News
TORONTO, May 30, 2025 — Two proudly Canadian pharmaceutical companies announced today a strategic partnership that reinforces their shared commitment to serving Canadian patients. Under the agreement, Pharmaris will assume responsibility for all sales and marketing activities for Vimy Pharma product portfolio across Canada.
This landmark collaboration unites two homegrown Canadian pharmaceutical organizations, both with deep roots in the Canadian healthcare landscape. The partnership exemplifies Canadian innovation and entrepreneurship in action, while strengthening domestic pharmaceutical capabilities and expertise.
Pharmaris Canada to Lead Sales and Marketing for Vimy Pharma Products Across Canada
Vimy Pharma Partners with Wounded Warriors Canada, Pledges Portion of Profits to Support Veterans and First Responders
TORONTO, July 8, 2025 — Vimy Pharma, a proudly Canadian pharmaceutical company dedicated to producing high-quality, affordable medicines, today announced a partnership with Wounded Warriors Canada, a national leader in mental health services for Veterans, First Responders, and their families.
As part of this partnership, Vimy Pharma is pledging a percentage of its profits to support Wounded Warriors Canada’s vital programs, which provide life-changing mental health resources and support to those who have served Canada at home and abroad.
Organizational update regarding Dr. Sean Wharton
Vimy Pharma would like to thank Dr. Wharton for his support as Chief Medical Officer and to announce that, effective June 2025, he is no longer in that role.
Vimy Pharma remains committed to its three-part mission to increase access to important medicines for Canadians and contribute to the sustainability of the healthcare system, while supporting Canadian manufacturing. Vimy Pharma would also like to recognize Dr. Wharton for his important work as a global key opinion leader in the field of chronic disease, helping to bring treatment guidelines and options to patients living with chronic disease.